$20M Public Offering Prices at $3.50/Share, NRx Pharma Stock Falls 11%
NRXP has more than doubled off its 52-week low of $1.62 on elevated volume (3.0× avg).
Summary
NRx Pharmaceuticals priced a $20 million public offering of 5.7 million shares at $3.50 per share, leading to an 11% drop in its stock. This offering, which includes an option for underwriters to purchase an additional 857,000 shares, is highly dilutive given the company's market capitalization. The capital raise is crucial for working capital and general corporate purposes, especially as the company has previously disclosed 'going concern' warnings in its recent 10-K and 10-Q filings and reported a Q1 revenue miss. The offering is expected to close on Thursday.
At the time of this announcement, NRXP was trading at $4.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $147.6M. The 52-week trading range was $1.62 to $5.06. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.